ATI Gets $450M Army Contract Modification for Coronavirus Antibody Production

Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.

The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.

Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.

ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.

GovCon Wire Logo

Receive the Daily News Briefing And Events Updates Straight to Your Inbox

Related Articles